Antiglutamic Acid Decarboxylase 65 (GAD 65) Antibody-Associated Encephalitis Characterized with Choreo-dystonic Movements, Responsive to Steroid: A Case Report

conducted, using the I2 for statistical heterogeneity.GRADE criteria were used to identify the certainty of evidence. ResultsA total of 1598 studies were screened, and 13 studies were selected, representing a total of 358 patients with axonal GBS.All of them were observational studies.The pool proportion for clinical improvement at 4 weeks was 33% CI 95% [24%, 44%], and for achieving independent walking at 6 months was 75% CI 95% [60%, 85%].Only two studies reported IVIG vs Plasmapheresis showing a pooled OR of 3.59 CI 95% [0.71 , 18.02 ].Quality assessment showed a low-medium risk of bias. ConclusionsWith a low certainty, our findings suggest that IVIG could improve functional outcomes in patients with axonal GBS.There was no significant difference of efficacy between IVIG and plasmapheresis; however, larger randomized controlled trials are needed to confirm this finding.Study Supported By: N/A.

Authors

Publication Details

Journal
Neurology
Published
2024-10-08
DOI
https://doi.org/10.1212/01.wnl.0001051936.61622.e9
Citations
1
Primary Topic
Neurological and metabolic disorders
Type
article
Field-Weighted Citation Impact
0.36
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antiglutamic Acid Decarboxylase 65 (GAD 65) Antibody-Associated Encephalitis Characterized with Choreo-dystonic Movements, Responsive to Steroid: A Case Report

Ariol Labrada, Mikaela Camacho Olalla, Roberto Sanchez, Maria Belen Solis Mayorga et al.
1 citations
Neurology
Neurological and metabolic disorders
0.36
article

Antiglutamic Acid Decarboxylase 65 (GAD 65) Antibody-Associated Encephalitis Characterized with Choreo-dystonic Movements, Responsive to Steroid: A Case Report

Ariol Labrada, Mikaela Camacho Olalla, Roberto Sanchez, Maria Belen Solis Mayorga, Aditi Agrawal
article en
1 citations

Abstract

conducted, using the I2 for statistical heterogeneity.GRADE criteria were used to identify the certainty of evidence. ResultsA total of 1598 studies were screened, and 13 studies were selected, representing a total of 358 patients with axonal GBS.All of them were observational studies.The pool proportion for clinical improvement at 4 weeks was 33% CI 95% [24%, 44%], and for achieving independent walking at 6 months was 75% CI 95% [60%, 85%].Only two studies reported IVIG vs Plasmapheresis showing a pooled OR of 3.59 CI 95% [0.71 , 18.02 ].Quality assessment showed a low-medium risk of bias. ConclusionsWith a low certainty, our findings suggest that IVIG could improve functional outcomes in patients with axonal GBS.There was no significant difference of efficacy between IVIG and plasmapheresis; however, larger randomized controlled trials are needed to confirm this finding.Study Supported By: N/A.

NeurologyVol. 103(7_Supplement_1)
Good health and well-being
Openalex Percentile: Top 33%
Neurological and metabolic disorders
0.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Antiglutamic Acid Decarboxylase 65 (GAD 65) Antibody-Associated Encephalitis Characterized with Choreo-dystonic Movements, Responsive to Steroid: A Case Report — Ariol Labrada, Mikaela Camacho Olalla, et al. · Neurology (2024) | TGRS Research Map | TGRS